Release Date: 05/06/14 08:27 Summary: Voluntary Delisting from OTCQX Price Sensitive: No Download Document 328.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%